Insys has a strong balance sheet, no long-term debt and cash flow that appears adequate to address potential liabilities, given the size of the Valeant settlement, Trbovich said.

John Kapoor had already shown himself to be a shady businessman before he started Insys around 2002. An earlier pharma company he ran, Lyphomed, ran afoul of the Food and Drug Administration in ...

BOSTON — A federal appeals court on Wednesday upheld the jury convictions of Insys Therapeutics Inc founder John Kapoor and four other company officials, over their roles in a scheme to bribe doctors ...

Boston - John Kapoor, the founder of Insys Therapeutics Inc, on Thursday was sentenced to 66 months in prison for his role in a bribery and fraud scheme that contributed to the U.S. opioid crisis ...

Amidst a "fire sale" restructuring of bankrupt Insys, the former maker of notorious fentanyl spray Subsys, opioid plaintiffs are still hoping to pick some meat off the drugmaker's bones.

Shares from opioid maker Insys Therapeutics Inc. will be delisted from the Nasdaq on June 19, the company said in a government filing on Tuesday.. The news follows the company's Chapter 11 ...

Insys Therapeutics founder and executives were convicted of bribing doctors to prescribe highly addictive painkiller. Advertisement. Drugs. World United States & Canada.

Insys Therapeutics filed for Chapter 11 on Monday, just five days after it agreed to pay $225 million to settle a Justice Department probe into bribes it paid doctors to get them to prescribe its ...

Opioid manufacturer Insys Therapeutics filed for Chapter 11 bankruptcy protection on Monday. Newsletters Games Share a News Tip. Featured. Featured. Breaking News. White House Watch.

As of Dec. 31, Insys had 226 full-time employees. The company reported a 2018 net loss of $124.3 million, or $1.68 a share, on revenue of $82.1 million, after a loss of $227.0 million, or $3.12 a ...

FILE PHOTO: John Kapoor, the billionaire founder of Insys Therapeutics Inc, leaves the federal courthouse in Boston, Massachusetts, U.S., March 13, 2019.

Insys warned investors in May that its legal costs could lead it to file for bankruptcy protection. The company’s stock has fallen to 60 cents Monday morning from about $7 one year ago.